Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiran Darou is an Iranian pharmaceutical company focused on the development, manufacturing, and distribution of high-tech medicinal products, particularly in the fields of biotechnology and specialized therapeutics. The company specializes in producing complex molecules including recombinant proteins, peptides, and high-potency small molecules for chronic and rare diseases. Their portfolio primarily targets metabolic disorders, hematology, and endocrinology, with a significant emphasis on providing affordable alternatives to expensive imported medications. Jiran Darou operates advanced manufacturing facilities that comply with international GMP standards to serve both the domestic Iranian market and regional export markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jiran Darou.